Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index; 2 of the 17 sources its claims cite were checked for support.

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE

Open access
Zaminski, Devyn, Saxena, Amit, Izmirly, Peter, Buyon, Jill P, Belmont, H Michael · 2023 · Lupus Science & Medicine

Abstract

OBJECTIVE: immunofluorescence test (CLIFT). To address the clinical impact of measuring these antibodies by two different assays, this study leveraged a well-phenotyped multiethnic/racial cohort. METHODS: All patients fulfilled the classification criteria for SLE by at least one of the validated schemes: American College of Rheumatology, Systemic Lupus Erythematosus International Collaborating Clinics and/or American College of Rheumatology/European League Against Rheumatism classification criteria. Patients with one or more simultaneously paired anti-dsDNA by multiplex EIA and CLIFT were identified. Analysis of concordance or discordance, titre comparability of assays and association with hybrid SLE Disease Activity Index score, prevalence of lupus nephritis (LN), ability to predict a flare and classification criteria was performed. RESULTS: 207 patients were simultaneously tested by EIA and CLIFT at least once for anti-dsDNA, generating 586 paired results. 377 pairs were concordant and 209 were discordant. 41 of 207 patients always had discordant paired results and 39 patients always had results with titre discordance. In 100 patients with LN, 60 were positive by EIA and 72 by CLIFT. Sensitivities and specificities for patients with LN versus patients without LN were EIA 60% and 47%, and CLIFT 72% and 37%, respectively. 42 patients had flare assessment within 90 days of their paired result. Six of seven patients with mild flares and all four patients with severe flares had concordant positive results. CONCLUSION: Our data demonstrate that discordance of positivity between both assays for anti-dsDNA is relatively common, occurring in a fifth of patients overall and a third of visits. EIA positivity is associated with LN less often than CLIFT positivity. With the significant discordance of results between anti-dsDNA assays, obtaining both CLIFT and EIA assays may be beneficial for classification and routine monitoring of SLE.

Overview

CoChat Summary

## TL;DR

This retrospective cohort study in 207 patients with SLE found that anti-dsDNA results by multiplex EIA and CLIFT were frequently discordant: 36% of 586 paired results and 20% of patients had discordant positivity. EIA positivity was less associated with lupus nephritis than CLIFT positivity, and the authors conclude that using both assays may help with diagnosis and routine monitoring.

## Key findings

  • Among 207 patients, there were 586 paired anti-dsDNA results; 377 pairs (64%) were concordant and 209 (36%) were discordant.
  • At the patient level, 41 of 207 patients (20%) were always discordant; including fluctuating cases, 88 patients had discordant results at least once.
  • In 100 patients with lupus nephritis (LN), 60 had at least one positive EIA result and 72 had at least one positive CLIFT result; sensitivity/specificity were 60%/47% for EIA and 72%/37% for CLIFT.
  • Among 250 positive concordant paired results, 141 (56%) had titre discordance; 39 of 98 patients (40%) with these positive concordant results always had titre discordance.
  • For flare prediction, 42 patients had assessment within 90 days: 6 of 7 mild flares and all 4 severe flares had concordant positive results before the flare.

## Methods

  • Retrospective analysis of a diverse New York University Lupus Cohort of patients with SLE seen at NYU Langone Health and Bellevue Hospital Center since 2014.
  • Included 207 patients who had one or more simultaneous paired anti-dsDNA tests by multiplex EIA and CLIFT; analyses used 586 paired results.
  • Compared assay concordance/discordance, titre concordance, hybrid SLEDAI scores, LN prevalence and test characteristics, flare prediction within 90 days, and whether anti-dsDNA positivity affected classification criteria; sensitivity, specificity, PPV, and NPV were calculated.

## Limitations

  • Stated by the paper: only the multiplex EIA was studied, not other EIA methods; test selection was not protocolised and depended on the ordering provider; titre tertiles were arbitrarily defined; LN classification may have reflected prior damage rather than active nephritis; not all LN patients had both tests; flare analysis had limited power because only 9% of paired visits had a follow-up encounter within 90 days.
  • Evident from the text: this was a retrospective observational study, so associations cannot establish causality.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/lupus-2023-001012

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flow chart depicting concordance and discordance of EIA and CLIFT by (A) patients and (B) the 586 paired results. CLIFT, Crithidia luciliae immunofluorescence test; EIA, enzyme immunoassay.
Figure 1 Flow chart depicting concordance and discordance of EIA and CLIFT by (A) patients and (B) the 586 paired results. CLIFT, Crithidia luciliae immunofluorescence test; EIA, enzyme immunoassay.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 2 Not valid · 6 Not checked · 38 Own results and interpretations

17 more claims

Create a free account to see all 46 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 18
  • The quote only partly states this claim. 2
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Citations

Cites

Show all 26 references

Research works printed but not linked: 3

  1. Kunkel HG . Advances in immunology. New York London: Academic Press, 1982.
  2. Ghirardello, 2011, Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays, Clin Exp Rheumatol, 29, 50
  3. 10.1016/j.cca.2011.02.025 · DOI

Cited by

See all 5

Metadata

Authors
Zaminski, D., Saxena, A., Izmirly, P., Buyon, J. P., & Belmont, H. M.
Affiliations
  • NYU Langone Health (US)
  • New York University (US)
Corresponding author
Zaminski, Devyn
Venue
Lupus Science & Medicine
Publisher
BMJ
Published
2023-11
Volume
10
Issue
2
Pages
e001012
ISSN
2053-8790 (ISSN-L)
OpenAlex
W4388706765
Cited by
5
References
26
Citations by year
2026: 1 · 2025: 2 · 2024: 2
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • Lupus Science & Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
systemic lupus erythematosus, anti-dsDNA antibodies, assay concordance, lupus nephritis, disease flare prediction, SLE classification criteria, multi-ethnic cohort
MeSH terms
Antibodies, Antinuclear, Crithidia, DNA, Fluorescent Antibody Technique, Humans, Immunoassay, Lupus Erythematosus, Systemic, Lupus Nephritis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE. https://app.cochat.ai/papers/10.1136/lupus-2023-001012
The paper
Zaminski, D., Saxena, A., Izmirly, P., Buyon, J. P., & Belmont, H. M. (2023). Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE. Lupus Science & Medicine. https://doi.org/10.1136/lupus-2023-001012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.